Compared with placebo, semaglutide lowered risks for adverse kidney outcomes and mortality across the chronic kidney disease spectrum, according to study data published in Clinical Journal of the ...

Higher BMI may protect against cardiovascular events in CKD patients. Discover how long-term weight patterns affect risk. Read more.

Out-of-sequence kidney transplants, including unilateral allocations, increased substantially between 2020 and 2024, according to study data published in JAMA Network Open. Out-of-sequence kidney ...

Chronic kidney disease isn’t fully reversible, but early diagnosis, medical care, and lifestyle changes can slow progression, ...

Continued FDA approval of iptacopan was contingent on 2-year trial data ...

In addition to delivering two approved medicines to Biogen’s portfolio, the acquisition of Apellis Pharmaceuticals will ...

To stay on top of renal health, make sure you add healthy habits to your kidneys, from rectifying diet practices to being more active.

SAN DIEGO, CA / ACCESS Newswire / April 6, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to ...

Dialysis, a life-saving treatment for kidney failure, is generally not painful, experts say. While minor discomfort may occur ...

The database will be created in partnership with the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at ...

Biogen will acquire Apellis for 5.6 billion dollars, adding two approved therapies and boosting growth in immunology and ...

Top-line results from the OBERON and TITANIA trials showed that tozorakimab reduced the annualised rate of moderate-to-severe ...